NLRP3 and prostate carcinoma: Because hypoxia in prostatic tumors is associated with chronic inflammation and a poor outcome for prostate cancer patients [19, 21, 32, 33], we investigated whether hypoxia in human PrECs, prostate cancer and myeloid cell lines promotes NLRP3 and AIM2 inflammasome activation.